The Cardiovascular Actions of DOPA Mediated by the Gene Product of ocular albinism 1

• 主要な著者: Yoshio Goshima (著者), Fumio Nakamura (著者), Daiki Masukawa (著者), Sandy Chen (著者), Motokazu Koga (著者)
• フォーマット: 図書
• 出版事項: Elsevier, 2014-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

l-3,4-Dihydroxyphenylalanine (DOPA) is the metabolic precursor of dopamine, and the single most effective agent in the treatment of Parkinson's disease. One problem with DOPA therapy for Parkinson's disease is its cardiovascular side effects including hypotension and syncope, the underlyin...